Jackson Creek Investment Advisors LLC Eagle Pharmaceuticals, Inc. Transaction History

Jackson Creek Investment Advisors LLC

  • $338 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023
SELL
$25.06 - $34.09 $175 - $238
-7 Reduced 0.03%
25,164 $714,000
Q4 2022

Feb 03, 2023
BUY
$24.98 - $39.77 $628,771 - $1 Million
25,171 New
25,171 $736,000
Q2 2022

Aug 04, 2022
SELL
$41.26 - $51.35 $931,361 - $1.16 Million
-22,573 Closed
0 $0
Q1 2022

May 03, 2022
BUY
$44.58 - $52.6 $1.01 Million - $1.19 Million
22,573 New
22,573 $1.12 Million

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email